# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025, Regulation 24: Amendment to regulation 32

Extent: E+W+S+N.I.

In regulation 32 (notification of adverse events), for “subject”, in each place where it occurs, substitute “participant”.

---
Source: https://www.legislation.gov.uk/uksi/2025/538/regulation/24 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-regulations-2025/regulation-24
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.